This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sonenshein, A L
Right arrow Articles by Fisher, S H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonenshein, A L
Right arrow Articles by Fisher, S H

 Previous Article  |  Next Article 

J Bacteriol. 1977 October; 132(1): 73-79

Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis.

A L Sonenshein, H B Alexander, D M Rothstein and S H Fisher

ABSTRACT

Lipiarmycin inhibited the activity of deoxyribonucleic acid-dependent ribonucleic acid (RNA) polymerase in vitro. We showed that inhibition was due to interference by lipiarmycin with the activity of sigma-containing molecules of RNA polymerase. Transcription by core enzyme was relatively resistant to the drug, but addition of sigma led to highly drug-sensitive RNA synthesis. We isolated lipiarmycin-resistant mutants of Bacillus subtilis and characterized them genetically and biochemically. Drug-resistant mutants contained an altered RNA polymerase that was resistant to the drug in vitro. By separation and mixed reconstitution of core and sigma fractions of mutant and wild-type RNA polymerase, we showed that lipiarmycin resistance in one mutant strain was a property of the core fraction. Genetic mapping experiments indicated that at least two lpm mutants are located between loci determining rifampin resistance and streptolydigin resistance.


J Bacteriol. 1977 October; 132(1): 73-79




This article has been cited by other articles:

  • Karlowsky, J. A., Laing, N. M., Zhanel, G. G. (2008). In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficile. Antimicrob. Agents Chemother. 52: 4163-4165 [Abstract] [Full Text]  
  • Gualtieri, M., Villain-Guillot, P., Latouche, J., Leonetti, J.-P., Bastide, L. (2006). Mutation in the Bacillus subtilis RNA Polymerase {beta}' Subunit Confers Resistance to Lipiarmycin. Antimicrob. Agents Chemother. 50: 401-402 [Full Text]